Cargando…
Hormone signaling via androgen receptor affects breast cancer and prostate cancer in a male patient: A case report
BACKGROUND: Male breast cancer (MBC) is rare, accounting for only around 1% of all breast cancers. Most MBCs are hormone-driven. Not only the estrogen receptor (ER), but also other steroid hormone receptors, including the androgen receptor (AR) and progesterone receptor (PgR) are expressed in MBC. A...
Autores principales: | Takuwa, Haruko, Tsuji, Wakako, Shintaku, Masayuki, Yotsumoto, Fumiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303965/ https://www.ncbi.nlm.nih.gov/pubmed/30577860 http://dx.doi.org/10.1186/s12885-018-5216-6 |
Ejemplares similares
-
Patients who achieved long-term clinical complete response and subsequently terminated multidisciplinary and anti-HER2 therapy for metastatic breast cancer: A case series
por: Takuwa, Haruko, et al.
Publicado: (2018) -
Pegfilgrastim-induced fatigue and leukocytosis improved following dose reduction in a young patient with breast cancer: A case report
por: Takuwa, Haruko, et al.
Publicado: (2019) -
Localized primary amyloidosis of the breast: a case report and review of the literature
por: Tsuji, Wakako, et al.
Publicado: (2016) -
Androgen Receptor Imaging in the Management of Hormone-Dependent Cancers with Emphasis on Prostate Cancer
por: Kairemo, Kalevi, et al.
Publicado: (2023) -
Phosphorylation of the Androgen Receptor by PIM1 in Hormone Refractory Prostate Cancer
por: Ha, Susan, et al.
Publicado: (2012)